MetaCap

LeMaitre Vascular Inc. (LMAT)

NASDAQ: LMATHealth CareMedical/Dental InstrumentsUSD

73.61-1.25 (-1.67%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LMAT stock chart

Technical analysis

Key statistics

All statistics
Dividend yield
1.29% ($0.95)
Ex-dividend date
Nov 19, 2026
52-week range
73.44 – 118.01
Day range
73.44 – 76.44
Volume / Avg
313.55K / 277.19K
Beta
—

52-week range

$73.44$118.01

LMAT stock today

LeMaitre Vascular (LMAT) closed at $73.61 on Nov 20, down 1.67% (-$1.25), versus the S&P 500's 3.70% decline. At this level, LMAT sits near the bottom of its 52-week range of $73.44 to $118.01: 37.6% below the high, set on Apr 14, 2026 and 0.2% above the low. LMAT is down 9.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 16.3%.

LeMaitre Vascular trades at 26.8x its trailing twelve-month earnings per share of $2.75. Its forward P/E of 23.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. LeMaitre Vascular pays an annual dividend of $0.95 per share, a 1.29% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About LeMaitre Vascular

Company profile

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services.

Industry
Medical/Dental Instruments
CEO
Mr. George W. LeMaitre
Headquarters
Burlington, MA
Employees
646
IPO year
2006

Financial highlights

Full financials

In fiscal 2025, LeMaitre Vascular generated $249.6 million in revenue, up 13.5% from fiscal 2024, its 13th consecutive year of revenue growth. Net income was $57.7 million (+31.1% year over year), for a net margin of 23.1% versus a median of 16.4% in the prior 5 years. Gross margin was 71.5% (up from 68.6%) and operating margin 27.2%.

LeMaitre Vascular annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$249.60M$219.86M$193.48M$161.65M$154.42M
Growth+13.53%+13.63%+19.69%+4.68%+19.37%
Net income$57.73M$44.04M$30.11M$20.64M$26.91M
EPS (diluted)$2.52$1.93$1.34$0.93$1.25

Analyst forecast

Forecast

Consensus (8 analysts)

buy

Avg. price target

$99.29+34.89%

  • Strong buy 2
  • Buy 2
  • Hold 4
  • Sell 0
  • Strong sell 0

Target range

Low $81.00High $132.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$0.62 vs $0.69
Surprise
-10.14%

Dividends

Dividend history
Annual dividend
$0.95
Last payment
$0.25
Ex-dividend date
Nov 19, 2026
Pay date
Dec 3, 2026

LMAT news

All LMAT news

LeMaitre Vascular peers

Health Care sector
LMAT peer companies
CompanyPrice% ChgMarket capCompare
XRAYDENTSPLY SIRONA Inc.8.29-2.36%$1.65Bvs LMAT
INSPInspire Medical Systems Inc.55.10-2.10%$1.60Bvs LMAT
KMTSKestra Medical Technologies Ltd.25.10-5.75%$1.50Bvs LMAT
PRCTPROCEPT BioRobotics Corporation24.70-4.08%$1.42Bvs LMAT
NVCRNovoCure Limited10.71+0.19%$1.25Bvs LMAT
TNDMTandem Diabetes Care Inc.17.46+3.93%$1.22Bvs LMAT
UFPTUFP Technologies Inc.290.85-2.70%$2.25Bvs LMAT
DRTSAlpha Tau Medical Ltd.11.76+3.93%$1.09Bvs LMAT

Indexes, lists and sector

LeMaitre Vascular stock FAQ

What is LeMaitre Vascular's stock price today?

LMAT last traded at $73.61 as of Nov 20, 4:00 PM EST, down 1.67% on the day. Prices are delayed at least 15 minutes.

Does LeMaitre Vascular pay a dividend?

Yes. LeMaitre Vascular pays $0.95 per share annually, a 1.29% yield. The most recent dividend of $0.25 had an ex-dividend date of Nov 19, 2026.

What is LMAT's P/E ratio?

LMAT trades at a trailing P/E ratio of 26.77 and a forward P/E of 23.37.

Who is LeMaitre Vascular's CEO?

Mr. George W. LeMaitre is the chief executive officer of LeMaitre Vascular Inc., which has about 646 employees.

What is the LMAT 52-week high?

The 52-week high for LMAT is $118.01 and the 52-week low is $73.44. The stock is currently 37.6% below its high.

Compare LMAT